Navigation Links
Mission Pharmacal Launches CitraNatal(R) Assure Prescription Prenatal Vitamin
Date:12/8/2008

Designed to ensure comfort and optimize nutrition for women and their babies

SAN ANTONIO, Dec. 8 /PRNewswire/ -- Mission Pharmacal today announced the addition of CitraNatal(R) Assure to its CitraNatal(R) family of prescription prenatal vitamins. CitraNatal Assure builds on the benefits of the CitraNatal line and offers increased nutrients for women and their babies.

Prenatal vitamins are an important resource for women who are pregnant or planning to become pregnant. They provide women with the essential vitamins and minerals they may be lacking from a healthy diet alone.

"CitraNatal Assure provides women with all the prenatal essentials of the CitraNatal line, and also offers increased levels of several vitamins and minerals," said Neill Walsdorf, Jr., President of Mission Pharmacal. "Mission Pharmacal is proud to add this unique formulation to the CitraNatal family to offer women another prenatal option to meet their individual needs."

CitraNatal Assure contains 300mg of Martek's life'sDHA(TM), a patented, plant-based form of the omega-3 fatty acid DHA, which is consistent with current published guidelines for pregnant and lactating women(1). DHA is the recommended essential fatty acid for prenatal care. It has been shown to be instrumental in the baby's pre- and postnatal brain, eye and nervous system development, increase the baby's gestation period, birth weight and size, lead to higher visual acuity at age 60 days, and increase cognitive and psychomotor developments(2,3,4). DHA cannot be produced naturally by the body; it must be gathered from diet or supplements.

CitraNatal Assure also offers increased levels of iron and vitamin B6. Vitamin B6 contributes to a baby's developing brain and nervous system(5) and may help some women reduce severe nausea or vomiting during pregnancy(6). It also helps the body maintain blood glucose levels, meta
'/>"/>

SOURCE Mission Pharmacal Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months
2. Alfacell Provides ONCONASE(R) NDA Submission Update
3. Zevalin(R) Following Short-Course Chemotherapy with CHOP + Rituximab (CHOP-R) Doubles Complete Remission Rate in First-Line Treatment of Follicular Non- Hodgkins Lymphoma
4. Joint Commission Urges Patients to Speak Up About Pain
5. Quigley Anti-Viral Compound QR448(a) Successfully Prevents Transmission of Infectious Bronchitis in Chickens
6. n-3 PUFAs Reduce Mortality and Hospital Admissions in Patients With Symptomatic Heart Failure
7. Oregon Tourism Commission Unveils New Online Customer Service Training Program
8. FDA Reviewing Biomoda Submission for Cancer Screening Study
9. FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
10. Eight-Year Melanoma Remission is Among Early Cancer Treatment Results
11. Patients Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 2015  Dr. Cal Robinson , Psy.D., ... Center today, providing patients with new methods ... through psychological counseling and treatment programs. ... medical psychologist with an extensive career in pain ... from assessment and treatment of behavioral medicine disorders ...
(Date:8/3/2015)... ANGELES, Aug. 3, 2015  CytRx Corporation (NASDAQ: ... in oncology, today reported financial results for the three ... overview of recent accomplishments and upcoming milestones for its ... 2015 has been very productive for CytRx. Enrollment in ... aldoxorubicin in soft tissue sarcoma (STS) continues on track ...
(Date:8/3/2015)... FREDERICK, Md. , Aug. 3, 2015  BioElectronics ... products for pain management, announced that Andrew J. ... Taylor on his program "On Business" at 9am ... to the interview live, tune to: ... to report on the exceptional acceptance the company,s flagship ...
Breaking Medicine Technology:Orthopaedic & Spine Center Introduces New Pain Psychologist 2CytRx Reports 2015 Second Quarter Financial Results 2CytRx Reports 2015 Second Quarter Financial Results 3CytRx Reports 2015 Second Quarter Financial Results 4CytRx Reports 2015 Second Quarter Financial Results 5CytRx Reports 2015 Second Quarter Financial Results 6CytRx Reports 2015 Second Quarter Financial Results 7CytRx Reports 2015 Second Quarter Financial Results 8CytRx Reports 2015 Second Quarter Financial Results 9CytRx Reports 2015 Second Quarter Financial Results 10CytRx Reports 2015 Second Quarter Financial Results 11CytRx Reports 2015 Second Quarter Financial Results 12CytRx Reports 2015 Second Quarter Financial Results 13CytRx Reports 2015 Second Quarter Financial Results 14UpTick News Wire Radio Show Will Interview BioElectronics' CEO Andrew Whelan 2
... 30 Wound Care,Innovations, LLC, a subsidiary of ... today that it will attend and exhibit at,the ... Boston. This,seminar is presented by HMP Communications, the ... and producers of the Symposium on,Advanced Wound Care. ...
... NIH; Findings could benefit,pregnant women worldwide, SEATTLE, ... and Human Development division of the National Institutes ... a $2.9 million grant,for a five-year research project ... known as preeclampsia and migraine., Dr. Williams ...
Cached Medicine Technology:Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R) 2Swedish in Seattle to Study Connections Between Preeclampsia and Migraine 2Swedish in Seattle to Study Connections Between Preeclampsia and Migraine 3
(Date:8/3/2015)... ... August 03, 2015 , ... They know every second ... St. Vincent Medical Center offers some of the best care in the nation. For ... neurointerventionalist, achieved the fastest average blood clot removal time in the country. During the ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... to contract research organisations (CROs) for a slew of benefits, allowing them to ... and operations, boost quality with cost-effective utilisation of resources, get access to innovation ...
(Date:8/3/2015)... CA (PRWEB) , ... August 03, 2015 , ... ... services to help patients in need. Most people know that general health emergencies, such ... Unfortunately, a fewer amount of people know where to turn to during a dental ...
(Date:8/3/2015)... ... ... AxoGen, Inc. (NASDAQ: AXGN), a leader in developing and marketing innovative surgical solutions ... Wednesday, August 12, 2015 at 9:45am (ET) at Le Parker Meridien in New York, ... be accessed via the investor relations section of the Company’s website. , About AxoGen, ...
(Date:8/3/2015)... , ... August 03, 2015 , ... A July 13 ... of Stem Cells Found to Release Natural Painkiller That Can Last 'For Five Weeks'" ... According to the report, the new study showed that harvesting stem cell-rich bone marrow ...
Breaking Medicine News(10 mins):Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 2Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 3Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 2Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 3Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 2Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 3Health News:AxoGen, Inc. to Present at the Wedbush Healthcare Conference 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3
... Ekahau Positioning Engine and Tags With ... Room Personnel, SARATOGA, California, July 30 Ekahau ... (RTLS), today announced,that the 12 de Octubre Hospital in ... is designed to improve security,and safety of its emergency ...
... 29 Microtest Laboratories has,launched a suite of ... U.S. that have yet failed to meet mandatory ... also announced,its offer of a free facility-gap-analysis audit ... level and corresponding,preparation., Pharmacies failing to comply ...
... Company,(NYSE: KVa/KVb), today reported that it is set ... -- principally cough/cold products -- previously,sold by ETHEX ... previously disclosed discussions with the FDA regarding the,agency,s ... by,ETHEX as well as other pharmaceutical companies for ...
... Challenge, SACRAMENTO, Calif., July 29 As ... Next 10 has just released,a newly updated version ... try their hand at dealing with the tradeoffs ... 2008 Budget Challenge, an online,interactive educational game, contains ...
... Pro Forma EPS Guidance, BETHESDA, Md., July 29 ... of $181.2 million for the,quarter ended June 30, 2008 an ... quarter. Net income increased by $2.9 million, or,57.2%, to $8.0 ... same,quarter last year., Pro forma net income applicable to ...
... LITTLE ROCK, Ark., July 29 Heifer International ... corporate partnership,agreement. Heifer International is a world hunger ... Greenfield, Indiana, that has,offices in 30 countries around ... improve animal health and productivity., The partnership ...
Cached Medicine News:Health News:Madrid Hospital Improves Employee Safety With Ekahau Wi-Fi RTLS 2Health News:Madrid Hospital Improves Employee Safety With Ekahau Wi-Fi RTLS 3Health News:Microtest Offers New Services, Free Facility Audit, for Compounding Pharmacies Seeking USP 797 Compliance 2Health News:Microtest Offers New Services, Free Facility Audit, for Compounding Pharmacies Seeking USP 797 Compliance 3Health News:KV Set to Dispose of Previously Written Off Guaifenesin Inventory 2Health News:KV Set to Dispose of Previously Written Off Guaifenesin Inventory 3Health News:As Budget Stalemate Wears On - Voters Can Set Their Own Priorities 2Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 2Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 3Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 4Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 5Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 6Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 7Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 8Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 9Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 10Health News:Heifer and Elanco Announce Charitable Partnership 2